Cetera Investment Advisers’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696K Buy
27,478
+7,265
+36% +$165K ﹤0.01% 3388
2026
Q1
$432K Buy
20,213
+3,405
+20% +$70.9K ﹤0.01% 3647
2025
Q4
$360K Buy
16,808
+5,481
+48% +$112K ﹤0.01% 3729
2025
Q3
$190K Buy
11,327
+1,219
+12% +$18.3K ﹤0.01% 4169
2025
Q2
$145K Buy
+10,108
New +$139K ﹤0.01% 3809
2024
Q3
Sell
-11,852
Closed -$89.5K 3851
2024
Q2
$89.5K Buy
+11,852
New +$98K ﹤0.01% 3528

Other funds holding MD

Cetera Investment Advisers's MD Position: Q2 2026 in Review

Cetera Investment Advisers increased its Pediatrix Medical (MD) stake by 36% in Q2 2026, buying an estimated $165K and bringing the position to 27,478 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #3388.

Cetera Investment Advisers first reported a position in MD in Q2 2024 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Cetera Investment Advisers held 27,478 shares of Pediatrix Medical worth $696K as of Q2 2026.
  • Cetera Investment Advisers bought 7,265 Pediatrix Medical shares in Q2 2026, an estimated $165K.
  • Pediatrix Medical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3388 holding.
  • Cetera Investment Advisers first reported a position in Pediatrix Medical in Q2 2024 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.